NDC00173-0434-00 by Glaxosmithkline Holdings Americas - Receive a Competitive Quote
| Part Number: NDC00173-0434-00 | Alternate P/N: NDC00173043400 | Manufacturer: Glaxosmithkline Holdings Americas | NSN : 6505-01-528-6335 | Item Name : Ceftazidime For Injection Usp | CAGE Code: 93544 | ||
We’re excited to announce that NDC00173-0434-00 NSN part is now available and ready for immediate shipping. Part number NDC00173-0434-00 is a Ceftazidime For Injection Usp manufactured by Glaxosmithkline Holdings Americas with NSN 6505015286335. Are you interested in a quick and competitive quote for this part?
Just NSN Parts, owned and operated by ASAP Semiconductor, is a leading distributor of NSN (National Stock Number) parts, new and obsolete. Because of our dedication to quality, we’re the only independent distributor in the United States with a strict No China Sourcing Pledge. We’re also an AS9120B, ISO 9001:2015 certified, and FAA AC 0056B accredited member of the Aviation Suppliers Association (ASA). Our vast and comprehensive inventory of over 2 billion parts coupled with our shipping facilities in Washington, Oregon, California, New Maxico, Nevada, Arizona, Illinois, Minnesota, Pennsylvania, and New York, allow us to offer you some of the fastest delivery times in the industry.
If you’d like to learn more about NSN part number NDC00173-0434-00 Ceftazidime For Injection Usp, feel free to call us at our toll-free number, +1-714-705-4780, or email us at sales@justnsnparts.com. And, if you’d like to stay informed on new inventory or any promotions, feel free to download the ASAP Semiconductor App from Google Play or the App Store.
NSN Information for Part Number NDC00173-0434-00 with NSN 6505-01-528-6335, 6505015286335
| NSN | FSC | NIIN | CLS | Hazmat | DEMIL | Cancelled NSN |
|---|---|---|---|---|---|---|
| 6505-01-528-6335 Item Description: Ceftazidime For Injection Usp | 6505 | 015286335 | M | P | ||
| CIIC | HCC | ESD | PMIC | Criticality | ENAC | |
| U | A | |||||
| Part Number | ISC | RNVC | RNCC | HCC | MSDS | SADC |
| Ndc00173-0434-00 | 2 | 2 | 3 |
Characteristics Data of NSN 6505-01-528-6335, 6505015286335
| MRC | Criteria | Characteristic |
|---|---|---|
| CSGS | ADMINISTRATION | INTRAVENOUS |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 1.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT |
| CQCT | PRIMARY CONTAINER TYPE | VIAL |
| AJUC | AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER | 81206 |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CEFTAZIDIME F/INJ 1GM ADD-VANTAGE VI TRAY OF 25S |
| SUPP | SUPPLEMENTARY FEATURES | ADD-VANTAGE VIALS TO BE USED BY ABBOTT ADD-VANTAGE DILUENT CONTAINERS ONLY |
| AGXW | PHYSICAL FORM | POWDER |
| CBBL | FEATURES PROVIDED | STERILE |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 1.000 GRAMS |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 25 |
| FEAT | SPECIAL FEATURES | STORE IN A DRY STATE, BETWEEN 15 AND 30 DEG. C; PROTECT FROM LIGHT; TO TREAT OR PREVENT INFECTIONS THAT ARE PROVEN OR STRONGLY SUSPECTED TO BE CAUSED BY BACTERIA; TRAY OF 25S |
